OncoDNA’s aim is to provide medical innovations based on targeted sequencing or complete sequencing of tumour genomes, in order to assist medical doctors in their treatment choices and/or give better monitoring of the evolution of patient tumors. The ambition is to be a European reference for personalized analysis in oncology, based on the analysis of tumour’s DNA from patients. OncoDNA provides innovative analyses to private hospitals, research centres and pharmaceutical clients.
Business Needs: Direct Sales, Distributor/Agent/Representative, Investor, Other
Products to be exported: OncoKDM
Countries of Interest: Armenia, Australia, Austria, Azerbaijan, Bahrain, Belarus, Belgium, Bhutan, Bosnia and Herzegovina, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Canada, China, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, France, Metropolitan, Georgia, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Kyrgyzstan, Latvia, Lebanon, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malaysia, Malta, Mexico, Moldova, Monaco, Montenegro, Morocco, Netherlands, Netherlands Antilles, New Zealand, Norway, Oman, Pakistan, Philippines, Qatar, Romania, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Africa, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Thailand, Turkmenistan, Ukraine, United Arab Emirates, United Kingdom, United States, Uzbekistan, Vatican City State, Vietnam, Yemen, Yugoslavia